Matthew Gline
CIK 1750094 · CEO · last filed 2026-04-20
Matthew Gline is a CEO who has filed 55 SEC Form 4 insider transactions across 2 companies since 2022. The most recent filing shows the insider sold $8.4M of ROIV on Apr 20, 2026. Across all open-market trades the lifetime net is −$71.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $502.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$502.75M
2
55
-$71.73M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ROIV | CEO | 16,736,116 | $30.04 | $502.75M | -$69.51M | 29 | 2026-04-20 |
| Roivant Sciences Ltd. (ROIVW) Delisted | CEO | 1,051,732 | $2.75 | $2.89M | -$2.22M | 26 | 2023-08-29 |
Recent Filings
55 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-20 | ROIV | Sell (S) | −289,774 | -$8.45M | EDGAR |
| 2026-04-01 | ROIV | Mixed | −261,191 | -$9.86M | EDGAR |
| 2025-12-17 | ROIV | Mixed | — | -$36.85M | EDGAR |
| 2025-09-18 | ROIV | Buy (P) | +3,315 | $50.0K | EDGAR |
| 2025-05-22 | ROIV | Tax (F) | −10,945 | -$120.8K | EDGAR |
| 2025-04-22 | ROIV | Tax (F) | −10,945 | -$111.1K | EDGAR |
| 2025-03-24 | ROIV | Tax (F) | −10,945 | -$120.1K | EDGAR |
| 2025-02-24 | ROIV | Tax (F) | −10,945 | -$117.3K | EDGAR |
| 2025-01-22 | ROIV | Tax (F) | −11,623 | -$129.6K | EDGAR |
| 2024-12-26 | ROIV | Tax (F) | −10,945 | -$126.6K | EDGAR |